News
Stars Insider on MSN5h
FDA approved: New medications and vaccinesThe year 2025 began with groundbreaking news for millions of Americans, following a landmark 2024 that introduced a wave of ...
French pharma major Sanofi and US partner Regeneron Pharmaceuticals yesterday presented positive results from the EVEREST ...
EAACI: Dupixent demonstrated superiority over Xolair (omalizumab) in chronic rhinosinusitis with nasal polyps in patients with coexisting asthma in first-ever presented phase 4 head-to-head respirator ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback